The SR protein family, Genome Biol, vol.10, p.242, 2009. ,
The SR protein family of splicing factors: master regulators of gene expression, Biochem J, vol.417, pp.15-27, 2009. ,
Regulation of alternative splicing by reversible protein phosphorylation, J Biol Chem, vol.283, pp.1223-1230, 2008. ,
Targeted disruption of an essential vertebrate gene: ASF/SF2 is required for cell viability, Genes Dev, vol.10, pp.2588-99, 1996. ,
Dephosphorylationdependent sorting of SR splicing factors during mRNP maturation, Mol Cell, vol.20, pp.413-438, 2005. ,
The impact of alternative splicing in vivo: mouse models show the way, RNA, vol.13, pp.1155-71, 2007. ,
Inactivation of the SR protein splicing factor ASF/SF2 results in genomic instability, Cell, vol.122, pp.365-78, 2005. ,
Topoisomerase I suppresses genomic instability by preventing interference between replication and transcription, Nat Cell Biol, vol.11, pp.1315-1339, 2009. ,
URL : https://hal.archives-ouvertes.fr/hal-00533325
Splicing regulator SRSF2 is essential for genomic stability and cell proliferation during mammalian organogenesis, Mol Cell Biol, vol.27, pp.5393-402, 2007. ,
Regulation of Ich-1 pre-mRNA alternative splicing and apoptosis by mammalian splicing factors, Proc Natl Acad Sci, vol.95, pp.9155-60, 1998. ,
Loss of splicing factor ASF/ SF2 induces G 2 cell cycle arrest and apoptosis, but inhibits internucleosomal DNA fragmentation, Genes Dev, vol.19, pp.2705-2719, 2005. ,
E2F1 controls alternative splicing pattern of genes involved in apoptosis through upregulation of the splicing factor SRSF2, Cell Death Differ, vol.15, pp.1815-1838, 2008. ,
Altered expression of heterogenous nuclear ribonucleoproteins and SR factors in human colon adenocarcinomas, Cancer Res, vol.58, pp.5818-5842, 1998. ,
Stagespecific changes in SR splicing factors and alternative splicing in mammary tumorigenesis, Oncogene, vol.18, pp.3574-82, 1999. ,
Expression of splicing factors in human ovarian cancer, Oncol Rep, vol.11, pp.1085-90, 2004. ,
The gene encoding the splicing factor SRSF1 is a proto-oncogene, Nat Struct Mol Biol, vol.14, pp.185-93, 2007. ,
Histone-deacetylase inhibitors: novel drugs for the treatment of cancer, Nat Rev Drug Discov, vol.1, pp.287-99, 2002. ,
Histone deacetylase inhibitors and the promise of epigenetic (and more) treatments for cancer, Nat Rev Cancer, vol.6, pp.38-51, 2006. ,
Histone deacetylase inhibitors: inducers of differentiation or apoptosis of transformed cells, J Natl Cancer Inst, vol.92, pp.1210-1216, 2000. ,
Novel mechanisms of apoptosis induced by histone deacetylase inhibitors, Cancer Res, vol.63, pp.4460-71, 2003. ,
A review of depsipeptide and other histone deacetylase inhibitors in clinical trials, Curr Pharm Des, vol.10, pp.2289-98, 2004. ,
p21(WAF1) is required for butyrate-mediated growth inhibition of human colon cancer cells, Proc Natl Acad Sci, vol.95, pp.6791-6797, 1998. ,
Histone deacetylase inhibitor selectively induces p21 WAF1 expression and gene-associated histone acetylation, Proc Natl Acad Sci, vol.97, pp.10014-10023, 2000. ,
Histone deacetylase (HDAC) inhibitor activation of p21 WAF1 involves changes in promoter-associated proteins, including HDAC1, Proc Natl Acad Sci, vol.101, pp.1241-1247, 2004. ,
780 induces p21 Waf1 gene transcription through releasing histone deacetylase 1 and estrogen receptor alpha from Sp1 sites to induce cell cycle arrest in MCF-7 breast cancer cell line, J Biol Chem, vol.280, pp.3185-96, 2005. ,
Treatment of spinal muscular atrophy by sodium butyrate, Proc Natl Acad Sci, vol.98, pp.9808-9821, 2001. ,
Restoration of the cystic fibrosis transmembrane conductance regulator function by splicing modulation, EMBO Rep, vol.5, pp.1071-1078, 2004. ,
Acetylation and phosphorylation of SRSF2 control cell fate decision in response to cisplatin, EMBO J, vol.30, pp.510-533, 2011. ,
Involvement of histone hyperacetylation in triggering DNA fragmentation of rat thymocytes undergoing apoptosis, FEBS Lett, vol.395, pp.183-190, 1996. ,
Apoptotic death in adenocarcinoma cell lines induced by butyrate and other histone deacetylase inhibitors, Biochem Pharmacol, vol.53, pp.1357-68, 1997. ,
Induction of caspase-3 protease activity and apoptosis by butyrate and trichostatin A (inhibitors of histone deacetylase): dependence on protein synthesis and synergy with a mitochondrial/ cytochrome c-dependent pathway, Cancer Res, vol.57, pp.3697-707, 1997. ,
Induction of p21 (WAF-1/CIP1) during differentiation, Oncogene, vol.9, pp.3389-96, 1994. ,
Sodium butyrate inhibits the phosphorylation of the retinoblastoma gene product in mouse fibroblasts by a transcription-dependent mechanism, J Cell Physiol, vol.166, pp.631-637, 1996. ,
Butyrate activates the WAF1/Cip1 gene promoter through Sp1 sites in a p53-negative human colon cancer cell line, J Biol Chem, vol.272, pp.22199-206, 1997. ,
Sodium butyrate induces growth arrest and senescence-like phenotypes in gynecologic cancer cells, Int J Cancer, vol.94, pp.257-67, 2001. ,
Level of reactive oxygen species induced by p21 Waf1/CIP1 is critical for the determination of cell fate, Cancer Sci, vol.100, pp.1275-83, 2009. ,
G 1 /S arrest induced by histone deacetylase inhibitor sodium butyrate in E1A + Ras-transformed cells is mediated through downregulation of E2F activity and stabilization of beta-catenin, J Biol Chem, vol.281, pp.21040-51, 2006. ,
Alteration of DNA and RNA binding activity of human telomere binding proteins occurs during cellular senescence, Exp Cell Res, vol.218, pp.241-248, 1995. ,
Modulation of the expression of p16 INK4a and p14 ARF by hnRNP A1 and A2 RNA binding proteins: implications for cellular senescence, J Cell Physiol, vol.193, pp.19-25, 2002. ,
Expressional changes in alternative splicing affecting genes during cell passage of human diploid fibroblasts, Mech Ageing Dev, vol.105, pp.105-119, 1998. ,
E2F1 induces apoptosis and sensitizes human lung adenocarcinoma cells to death-receptormediated apoptosis through specific downregulation of c-FLIP(short), Cell Death Differ, vol.13, pp.260-72, 2006. ,
A large-scale RNAi screen in human cells identifies new components of the p53 pathway, Nature, vol.428, pp.431-438, 2004. ,
Role of the histone acetyl transferase TIP60 in the p53 pathway, J Biol Chem, vol.279, pp.44825-44858, 2004. ,
URL : https://hal.archives-ouvertes.fr/hal-00320114
Tip60 and p400 are both required for UV-induced apoptosis but play antagonistic roles in cell cycle progression, EMBO J, vol.25, pp.1680-1689, 2006. ,
URL : https://hal.archives-ouvertes.fr/hal-00317897
p21 transcription is regulated by differential localization of histone H2A, Z. Genes Dev, vol.21, pp.1869-81, 2007. ,
The SANT domain of p400 ATPase represses acetyltransferase activity and coactivator function of TIP60 in basal p21 gene expression, Mol Cell Biol, vol.30, pp.2750-61, 2010. ,
Effects of p21 Waf1/Cip1/Sdi1 on cellular gene expression: implications for carcinogenesis, senescence and age-related diseases, Proc Natl Acad Sci, vol.97, pp.4291-4297, 2000. ,
Pseudo-DNA damage response in senescent cells, Cell Cycle, vol.8, pp.4112-4120, 2009. ,
Relative amounts of antagonistic splicing factors, hnRNP A1 and ASF/SF2, change during neoplastic lung growth: implications for pre-mRNA processing, Mol Carcinog, vol.41, pp.187-96, 2004. ,
An intact NFkappaB pathway is required for histone deacetylase inhibitorinduced G 1 arrest and maturation in U937 human myeloid leukemia cells, Cell Cycle, vol.2, pp.467-72, 2003. ,
Sodium butyrate inhibits cell growth and stimulates p21 WAF1/CIP1 protein in human colonic adenocarcinoma cells independently of p53 status, Nutr Cancer, vol.46, pp.202-213, 2003. ,
p21 Waf1/Cip1 is a common target induced by short-chain fatty acid HDAC inhibitors (valproic acid, tributyrin and sodium butyrate) in neuroblastoma cells, Oncol Rep, vol.13, pp.1139-1183, 2005. ,
Histone deacetylase inhibitors decrease proliferation potential and multilineage differentiation capability of human mesenchymal stem cells, Cell Prolif, vol.42, pp.711-731, 2009. ,